Jump to content

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial (Q77374966)

From Wikidata

scientific article published on 01 May 1999

Language	Label	Description	Also known as
default for all languages	No label defined
English	Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial	scientific article published on 01 May 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

Crohn's disease

1 reference

based on heuristic

inferred from title

10

object named as

P Rutgeerts

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

G D'haens

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Van Deventer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R Van Hogezand

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Chalmers

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Kothe

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Baert

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Braakman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Schaible

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

K Geboes

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

0 references

Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

116

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1029-1034

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestiv

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

A controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

A controlled double blind study of azathioprine in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Beneficial effects of tumour necrosis factor-alpha (TNF-α) blockade in rheumatoid arthritis (RA)

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

7 January 2021

Identifiers

10.1016/S0016-5085(99)70005-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77374966&oldid=1638020394"